St. Francis Cancer Center | St. Francis Cancer Center | NRG-GY012
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
2005
clinical-trial-template-default,single,single-clinical-trial,postid-2005,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.9,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Clinical Trials

NRG-GY012

NRG-GY012 – A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women with Recurrent, Persistent or Metastatic Endometrial Cancer. read more>

« Available Clinical Trials